CTT Pharma Gives Uplisting Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailTAMPA, FLORIDA / ACCESS Newswire / March 3, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) is expecting notification this week for uplisting status to the OTCQB. CTT will notify shareholders as more news becomes available.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Texas Instruments (TXN) to Buy
- Jefferies on argenx SE (ARGX): 'we think this is a good entry point post-Sjogren's & cont. to like ARGX's setup into YE'26'
- Canaccord on Spotify (SPOT): 'we see a case for further multiple expansion, even after today's move'
Create E-mail Alert Related Categories
ACCESS Newswire, Press ReleasesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
